Brown & Brown (BRO)
NYSEFinancialsInsurance BrokersSnapshot 2026-07-07
$69.28+1.24%
Close 2026-07-07 · 1-day change
Reading BRO? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track BRO free→NYSEFinancialsInsurance BrokersSnapshot 2026-07-07
Reading BRO? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track BRO free→QuarterlyIQ Insights · BRO
Price, fair value, and the multiples that frame it on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 12 valuation methods, at three horizons. Current price $69.28. As of 2026-07-08. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A long-thesis check that carries the widest uncertainty of the three horizons.
Above average on quality vs scored peers
A second lens on the 12-month fair value: for companies that score high on measured quality (profitability, balance-sheet safety, earnings stability), this read trusts more of today's profit margins instead of averaging them toward their multi-year history the way the headline number does. Shown alongside the fair value above, not in place of it. A diagnostic, not a price target or a buy/sell signal.
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $69 BRO trades at 16× p/e, below its 17× p/e peer median. Our $78 fair value sits above the price. We hold it with medium confidence: quality doesn't explain valuation multiples in this sub-industry, so the peer comparison is a weak guide. Not investment advice.
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
No fragility gates fired. Regime (Mania) does not concentrate fragility.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
Roughly priced in line with peers.
Cheaper than its own typical valuation.
Trailing four: 2025-Q1, 2025-Q2, 2025-Q3, 2026-Q1
Score 100 = cheapest in the cohort, 0 = richest. Bars are filled left-to-right based on the peer-relative score (or PEG/self-history where shown).
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| dcf fcfe | 12M | $170.53 | — | — | Hist. CAGR | high |
| dcf fcff | 12M | $182.38 | — | — | Hist. CAGR | high |
| ddm gordon | 12M | $8.28 | — | — | TTM | high |
| graham number | 12M | $60.87 | — | — | TTM | high |
| Peer P/B | 12M | $78.53 | 2.1 | 37.43 | TTM | high |
| Peer P/FCF | 12M | $56.96 | 13.6 | 4.19 | TTM | high |
| Peer P/E | 12M | $72.81 | 16.5 | 4.40 | TTM | high |
| Peer P/S | 12M | $64.07 | 3.4 | 18.99 | TTM | high |
| PEG | 12M | $59.54 | 13.5 | 4.40 | TTM | high |
| residual income | 12M | $42.91 | — | — | TTM | high |
| Own P/E history | 12M | $102.15 | 23.2 | 4.40 | TTM | high |
| triangulated | 12M | $74.57 | 16.5 | 4.51 | Triangulated | high |
| Peer P/B | 3Y | $119.43 | 2.1 | 56.92 | Hist. CAGR(prov.) | medium |
| Peer P/FCF | 3Y | $86.63 | 13.6 | 6.37 | Hist. CAGR(prov.) | medium |
| Peer P/E | 3Y | $94.11 | 16.5 | 5.69 | Analyst | medium |
| Peer P/S | 3Y | $86.60 | 3.4 | 25.67 | Analyst | medium |
| PEG | 3Y | $76.97 | 13.5 | 5.69 | Analyst | medium |
| Own P/E history | 3Y | $132.04 | 23.2 | 5.69 | Analyst | medium |
| Peer P/B | 5Y | $157.94 | 2.1 | 75.28 | Hist. CAGR(prov.) | high |
| Peer P/FCF | 5Y | $114.57 | 13.6 | 8.42 | Hist. CAGR(prov.) | high |
| Peer P/E | 5Y | $114.56 | 16.5 | 6.92 | Analyst | high |
| Peer P/S | 5Y | $105.42 | 3.4 | 31.24 | Analyst | high |
| PEG | 5Y | $93.69 | 13.5 | 6.92 | Analyst | high |
| Own P/E history | 5Y | $160.73 | 23.2 | 6.92 | Analyst | high |
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.